Zobrazeno 1 - 10
of 217
pro vyhledávání: '"G. Tekuzman"'
Publikováno v:
Clinical Infectious Diseases. 18:298-304
Fluconazole has proved to be effective in treating oropharyngeal and esophageal candidiasis in immunocompromised patients. However, sufficient data are lacking regarding the efficacy of this agent in neutropenic hosts. The aim of the present study wa
Publikováno v:
Journal of experimentalclinical cancer research : CR. 17(3)
Autor:
Y, Koc, G, Akpek, E, Kansu, A, Kars, G, Tekuzman, E, Baltali, N, Güler, I, Barista, I, Güllü, Y, Ozisik, D, Firat
Publikováno v:
Cancer investigation. 16(6)
Two consecutive phase II clinical studies were designed to evaluate the efficacy and safety of bolus and continuous infusion (CI) mitoxantrone (MTZ) in 39 patients with newly diagnosed acute lymphocytic leukemia (ALL). MTZ was used as part of the cla
Publikováno v:
Neoplasma. 45(1)
Over the past years, quality of life (QOL) in patients with breast cancer has continued to be a noteworthy area of research. The diagnosis and management of cancer can have a major impact on every aspect of a patient's QOL. Sixteen women with breast
Publikováno v:
Respiration; international review of thoracic diseases. 64(5)
Multiple chondromatous hamartomas are extremely rare and we have not found any bilateral presentation in the literature. We report the case of a 47-year-old woman presenting with a cough, chest pain and dyspnea. Chest x-ray and computed tomography re
Autor:
I H, Güllü, I, Celik, G, Tekuzman, M, Altunbaş, N, Güler, I, Barişta, N, Alkiş, S, Yalçin, A, Kars, E, Baltali, E, Kansu, D, Firat
Publikováno v:
Tumori. 82(3)
Forty patients with primary malignant brain tumor were treated by combination chemotherapy after prior treatment with surgery and radiotherapy. The chemotherapy schedule consisted of PCV: procarbazine per os, 100 mg/m2, during 14 consecutive days; CC
Publikováno v:
Anticancer research. 16(2)
Solitary bone plasmacytomas account for 5-7% of multiple myeloma cases and are assumed to have a fairly good prognosis, with a long duration of relapse-free survival after primary local treatment. Isolated phalanx plasmacytoma is a very rare entity,
Autor:
S. Aksoy, H. Abali, S. Kiliçkap, Ö. Yavas, B. Oyan, E. T. Elkiran, T. Aras, Ö. Ugurlu, N. Güler, G. Tekuzman
Publikováno v:
Journal of Clinical Oncology. 22:5615-5615
Publikováno v:
Journal of chemotherapy (Florence, Italy). 1
Autor:
D, Firat, G, Tekuzman
Publikováno v:
Cancer chemotherapy reports. 59(5)